Obesity and Reproductive Performance in Women
),
(1)
Corresponding Author
Abstract
Obesity and overweight are not only problem of developed nations but also an increasing problem in developing countries with health consequences. Studies have highlighted the link between obesity, infertility and adverse reproductive health outcome. Obesity contributes majorly to two most commonmedical risks in pregnancy: diabetes and hypertension. It is associated with increased risk of large-for-gestationalage and hypertensive disorders, including preeclampsia, whichmay be associated with low birth weight. Combination of factors viz individual lifestyle, environmental and genetic play role in obesity. Weight loss has demonstrated toimprove fertility in obese women throughrecovery of spontaneous ovulation, and improved response to ovarian stimulation in infertility treatment. Therefore, weight management interventions, should be considered for overweight and obese infertile women (Afr. J. Reprod. Health 2010; 14[3]: 143-151).
Résumé
Obésité et la performance de reproduction chez la femme. L’obésité et la surcharge pondérale sont non seulement des problèmes qui se posent aux pays avancés, mais aussi aux pays en développement avec des conséquences pour la santé. Des études ont souligné les liens entre l’obésité, la stérilité et les conséquences défavorables pour la santé de reproduction. L’obésité contribue de manière significative à deux risques médicaux les plus communs pendant la grossesse: le diabète et l’hypertension. Elle est associée au risque accru d’avoir une grossesse qui est plus grande que l’âge gestationnel et des désordres hypertensifs, y compris la pré- éclampsie qui peut être liée à un faible poids de naissance. Une combinaison de facteurs, c’est à dire le mode de vie individuel, l’environnement et les facteurs génétiques jouent un rôle dans l’obésité. On a démontré que la perte de poids améliore la fécondité chez les femmes obèses à travers le rétablissement spontané de l’ovulation et la réponse améliorée à la stimulation de l’ovaire dans le traitement de la stérilité. En conséquence, les interventions des modalités du traitement du poids doivent être considérées à l’égard des femmes stériles obèses et qui ont une surcharge pondérales (Afr. J. Reprod. Health 2010; 14[3]: 143-151).
References
Obesity Task Force, World Health Organization. Global Strategy On Diet, Physical Activity And Health:
Obesity and Overweight. 2005; Available: http://www.who.int/hpr/NPH/docs/gs_obesity.
Jackson D. Why Obesity is Winning, Boston Globe. 2005.
Baxter J. Obesity surgery- another unmet need. BMJ 2000; 321: 523 -524.
Colditz G. Economic costs of obesity. Am. J. Clin. Nutr. 1992; 55:503-7S.
Maxine Frith. Obesity In Britain Triples In 14years. Social Affair Correspondent. The Independent- UK. 26-4 http:// www.rense.com Retrieved 3rd July, 08
Timo E. Saaristo , Noël C. Barengo, Eeva KorpiHyövälti. High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population BMC Public Health 2008; 8:423 doi:10.1186/1471-2458-8-423
Australian Institute of Health and Welfare (AIHW) The eighth biannual health report of the AIHW. Australian Institute of Health and Welfare, Canberra. Australia’s health 2002.
Calle EE, Thun MJ, Petrelli JM, Rodriguez C and Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N. Engl. J. Med. 1999; 341,1097–1105.
Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ. Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003; 348,1625–1638.
Callaway LK, Prins JB, Chang AM, McIntyre HD. The prevalence and impact of overweight and obesity in an Australian population. Med. J. Aust. 2006 184:56–59. [PubMed]
Puoane T, Steyn K, Bradshaw D, Laubscher R, Fourie J, Lambert V, et al. Obesity in South Africa: the South African demographic and health survey. Obes. Res. 2002; 10:1038-1048.
Filozof C, Gonzalez C, Sereday M, Mazza C, Braguinsky J. Obesity prevalence and trends in Latin- American countries. Obestet. Rev. 2001; 2:99-106.
Rivera JA, Barquera S, Campirano F, Campos I, Safdie M, Tovar V. Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity. Public Health Nutr. 2002; 5:113-122.
Satpathy HK, Fleming A, Frey D, Barsoom M, Satpathy C, Khandalavala J. Maternal obesity preg. Postgrad Med. 2008; p 15;120 (3):E01-9. Department of OB-GYN, Creighton University Medical Center, Omaha, NE, 68105, USA. .
Bakari AG , Onyemelukwe GC, Sani BG, Aliyu IS, Hassan SS and Aliyu TM. Obesity, overweight and under weight in suburban northern Nigeria. Intl. J. Diabetes & Metabolism 2007; 15: 68-69
Obi Samuel N and Obute Ejike A. Pregnancy in the Obese Nigerian. Trop. J. Obstet. Gynaecol. 2004; 21(1): 32-35
Onche Odeh. Nigeria: Obesity, Diabetes Epidemics Loom. Daily Independent (Lagos) 31 October 2008 Posted to the web 31 October 2008 Assessed Nov, 21, 2008. All Africa.com:
Ramón A Durazo-Arvizu, Amy Luke, Richard S Cooper, Guichan Cao, Lara Dugas, Adebowale Adeyemo, Michael Boyne, and Terrence Forrester. Rapid increase in obesity in Jamaica compared to Nigeria and the United states. BMC Public Health 2008; 8: 133.
Sudi IY., Nathan MB and Ibrahim A. A Survey of Obesity in Adamawa State College of Agriculture, Mubi, Nigeria. J. Sustainable Dev. Agric. Environ. 2008; Vol. 3(2):138-142 ISSN: 0794-8867 © Paraclete Publishers
Akpa CN Mato: Obesity in Nigeria. Current trends and management. Nig. Med. Practitioner 2008; Vol. 54 (1):
-15
Senbanjo IO, Adejuyigbe EA. Prevalence of overweight and obesity in Nigerian preschool children. Nutr Health. 2007; 18(4):. 391-399.
Rosenberg TJ, Garbers S, Chavkin W, et al. Prepregnancy weight and adverse perinatal outcomes in an ethnically diverse population. Obstet. Gynecol. 2003; 102:1022–1027.
Linne Y. Effects of obesity on women’s reproduction and complications during pregnancy. Obes. Rev. 2004; 5:137–143.
Centre for Disease Control and Prevention: Online Source for credible health Information: Obesity and Genetics retrieved 2nd July, 2008 Page last reviewed: July 9, 2007 Page last modified: July 9, 2007 Content
Source: National Office of Public Health Genomics
Weiss JL, Malone FD, Emig D, et al. Obesity, obstetric complication and cesarean delivery rate—a population based screening study. Am J Obstet Gynecol. 2004;
:1091–1097. [CrossRef] [ISI] [Medline]
Cunningham FG, Gant NF, Leveno KJ, et al. Hypertensive disorders in pregnancy. eds. Williams Obstetrics. 21st ed. New York, NY: McGraw-Hill; 2001:567– 618.
Oladapo O O, Celestine O U, Aimakhu C O. Obstetric performance of Nigerian obese parturients. Trop. J. Obstet. Gynaecol. 2002,19:17 -20. Jo
Sorensen TI. Socioeconomic aspects of obesity: causes or effects. Int. J. Obes. Relat. Discord. 1995; 19 suppl 6:S6 -8
Obesity genetics. Genetic variation implicated in Pima obesity. Contact: Srikar Chamala Public release date: 16-Oct-2007 Inderscience Publishers.
Norman RJ, Davies MJ, Lord J and Moran LJ. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 2002; 13,251–257.
Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update 2003; 9:359-72.
Moran LJ, Norman RJ. The obese patient with infertility: a practical approach to diagnosis and treatment. Nutr Clin Care 2002; 5:290-7.
Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C and Jacobs HS Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum. Reprod. 1995; 10, 2107–2111.
Gambineri A, Pelusi C, Vicennati V, Pagotto U and Pasquali R. Obesity and the polycystic ovary syndrome. Int. J. Obes. Relat. Metab. Disord. 2002;
,883–896.
Carmina E, Legro RS, Stamets K, Lowell J and Lobo RA. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod. 2003; 18: 2289– 2293.
Norman RJ, Masters SC, Hague W, Beng C, Pannall P and Wang JX. Metabolic approaches to the sub classification of polycystic ovary syndrome. Fertil. Steril. 1995; 63,329–335.
Yildirim B, Sabir N and Kaleli B. Relation of intra- abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril 2003; 79,1358–1364.
Castracane VD and Henson MC. When did leptin become a reproductive hormone? Semin Reprod Med 2002; 20, 89–92.
Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weightreduced subjects. Nat Med 1995; 1, 1155–1161.
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL et al. Serum immunoreactiveleptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 1996; 334,292–295.
Vicennati V, Gambineri A, Calzoni F, Casimirri F, Macor C, Vettor R and Pasquali R. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels. Metabolism 1998; 47,988–992.
Chapman IM, Wittert GA and Norman RJ. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Clin Endocrinol (Oxf) 1997; 46,175–181.
Brzechffa PR, Jakimiuk AJ, Agarwal SK, Weitsman SR, Buyalos RP and Magoffin DA. Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1996; 81,4166–4169.
Rouru J, Anttila L, Koskinen P, Penttila TA, Irjala K, Huupponen R and Koulu M. Serum leptin concentrations in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1997; 82,1697–1700.
Gennarelli G, Holte J, Wide L, Berne C and Lithell H. Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome? Hum. Reprod. 1998; 13,535–541.
Duggal PS, Van Der Hoek, KH, Milner, CR, Ryan, NK, Armstrong, DT, Magoffin, DA and Norman, RJ. The in vivo and in vitro effects of exogenous leptin on ovulation in the rat. Endocrinology 200; 14:, 1971– 1976.
Ryan NK, Woodhouse CM, Van der Hoek KH, Gilchrist RB, Armstrong DT and Norman RJ. Expression of leptin and its receptor in the murine ovary: possible role in the regulation of oocyte maturation. Biol. Reprod. 2002; 66:1548–1554.
Ryan NK, Van der Hoek KH, Robertson SA and Norman RJ. Leptin and leptin receptor expression in the rat ovary. Endocrinology 2003; 144, 5006–5013.
Agarwal SK, Vogel K, Weitsman SR and Magoffin DA. Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granu-losa and theca cells of the human ovary. J. Clin. Endocrinol. Metab. 1999; 84,1072–1076.
Brannian JD, Zhao Y and McElroy M. Leptin inhibits gonadotrophin-stimulated granulosa cell progesterone production by antagonizing insulin action. Hum. Reprod. 1999; 14:1445–1448.
Loffler S, Aust G, Kohler U and SpanelBorowski K. Evidence of leptin expression in normal and polycystic human ovaries. Mol. Hum. Reprod. 2001; 7,1143–119.
Lake JK, Power C and Cole TJ. Child to adult body mass index in the 1958 British birth cohort: associations with parental obesity. Arch. Dis. Child 1997; 77,376–381.
Ibanez L, Potau N, Francois I and de Zegher F. Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J. Clin. Endocrinol. Metab. 1998; 83,3558– 3562.
Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ and Franks S. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992; 36,105–111.
Hamilton-Fairley D, Kiddy D, Watson H, Paterson C and Franks S. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonado-trophin. Br. J. Obstet. Gynaecol. 1992; 99,128–131.
Bohrer M and Kemmann E. Risk factors for spontaneous abortion in menotropin-treated women. Fertil. Steril. 1987; 48,571–575.
Bellver JEA. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil. Steril. 2003; 79,1136–1140.
Fedorcsak P, Storeng R, Dale PO, Tanbo T and Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta. Obstet. Gynecol. Scand. 2000; 79,43–48.
Winter E, Wang J, Davies MJ and Norman R. Early pregnancy loss following assisted reproductive technology treatment. Hum. Reprod. 2002; 17, 3220– 3223.
Fridstrom M, Nisell H, Sjoblom P and Hillensjo T. Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and/or preeclampsia? Hypertens. Preg. 1999; 18, 73– 80.
Michlin R, Oettinger M, Odeh M, Khoury S, Ophir E, Barak M, Wolfson M and Strulov, A. Maternal obesity and pregnancy outcome. Isr. Med. Assoc. J. 2000; 2,10–13.
Shepard MK, Balmaceda JP and Leija CG. Relationship of weight to successful induction of ovulation with clomiphene citrate. Fertil. Steril. 1979; 32,641–645.
Lobo RA, Gysler M, March CM, GoebelsmannU and Mishell DR Jr. Clinical and laboratory predictors of clomiphene response. Fertil. Steril. 1982; 37,168–174.
Friedman CI and Kim MH. Obesity and its effect on reproductive function. Clin. Obstet. Gynecol. 1985; 28,645–663.
Dickey RP, Taylor SN, Curole DN, Rye PH, Lu PY and Pyrzak R. Relationship of clomiphene dose and patient weight to successful treatment. Hum. Reprod. 1997; 12,449–453.
McClure N, McQuinn B, McDonald J, Kovacs GT, Healy DL and Burger HG. Body weight, body mass index and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome? Fertil. Steril. 1992; 622–624.
Crosignani PG, Ragni G, Parazzini F, Wyssling H, Lombroso G and Perotti L. Anthropometric indica-tors and response to gonadotrophin for ovulation induction. Hum. Reprod. 1994; 9,420–423.
Fedorcsak P, Dale PO, Storeng R, Tanbo T and Abyholm T. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum. Reprod. 2001; 16, 1086–1091.
Loh S, Wang JX and Matthews CD. The influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients. Hum. Reprod. 2002; 17,1207– 1211.
Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum. Reprod. 1998; 13:1502-5.
Kiddy DS, Hamilton-Fairley D, Seppala M, Koistinen R, James VH, Reed MJ and Franks S. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I. Clin. Endocrinol. (Oxf) 1989; 31,757– 63.
Hamilton-Fairley D, Kiddy D, Anyaoku V, Koistinen R, Seppala M and Franks S. Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction. Clin. Endocrinol. (Oxf) 1993; 39,363–367.
Andersen P, Seljeflot I, Abdelnoor M, Arnesen H, Dale PO, Lovik A and Birkeland K. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism 1995; 44,611–616.
Wahrenberg H, Ek I, Reynisdottir S, Carlstrom K, Bergqvist A and Arner P. Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1999; 84,2182–2187.
VanDam EW, Roelfsema F, Veldhuis JD, Helmerhorst FM, Frolich M, Meinders AE, Krans HM and Pijl H. Increase in daily LH secretion in response to shortterm calorie restriction in obese women with PCOS. Am. J. Physiol. Endocrinol. Metab. 2002; 282,E865– 872.
Pasquali R, Fabbri R, Venturoli S, Paradisi R, Antenucci D and Melchionda N. Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries. Am. J. Obstet. Gynecol. 1986; 154,139–144.
Pasquali R, Antenucci D, Casimirri F, Venturoli S, Paradisi R, Fabbri R, Balestra V, Melchionda N and Barbara L. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J. Clin. Endocrinol. Metab. 1989; 68,173–179.
Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M and Morselli-Labate AM. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2000; 85,2767–2774.
Holte J, Bergh T, Berne C, Wide L and Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1995; 80,2586–2593.
Jakubowicz DJ and Nestler JE. 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss. J. Clin. Endocrinol. Metab. 1997; 82,556– 60.
Moran LJ, Noakes M, Clifton PM, Tomlinson L and Norman RJ. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2003; 88,812–819.
Shick SM, Wing RR, Klem ML, McGuire MT, Hill JO and Seagle H. Persons successful at long-term weight loss and maintenance continue to consume a low-energy, low-fat diet. J. Am. Diet. Assoc. 1998; 98,408–413.
Heymsfield SB, van Mierlo CA, van der Knaap HC, Heo M and Frier HI. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int. J. Obes. Relat. Metab, Disord. 2003; 27,537–549.
Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X and Norman RJ. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum. Reprod. 1995; 10, 2705–2712.
Clark AM, Thornley B, Tomlinson L, Galletley C and Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum. Reprod. 1998; 13, 1502–1505.
Scalzo K. Case problem: dietary recommendations to combat obesity, insulin resistance and other concerns related to polycystic ovary syndrome. J. Am. Dietet Assoc. 2000; 100,955–957; discussion 957–960.
David E O. Obesity Part 2: Pharmacotherapy. The Internet Journal of Academic Physician Assistants 1997; Vol 1, number 2
National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA 1996; 276:1907-15.
Article Metrics
Abstract View
: 660 times
Download : 0 times
Refbacks
- There are currently no refbacks.
